OVERVIEW: The D.K. Kim International Center for Regulatory Science and the Regulatory Knowledge and Support (RKS) core of SC CTSI hosts symposia on current regulatory topics in clinical and translational science. Symposia are designed to address the needs of clinical research team members, but all interested are welcome to attend. The popular day-long events are typically attended by 150 to 200 clinical research professionals and students from academia and industry training for careers in drug development and clinical research.  Symposium qualifies for Continuing Education (CE) credits.

GOALS: To educate students and professionals at various stages of career pathways on current clinical research-related topics and developments in the regulatory environment presented by experts from academia, government, and industry.

CURRENT STATUS: The popular series, now in its sixth year, has been attended by thousands of clinical research professionals from 96 institutions. In response to the COVID-19 pandemic, RKS transitioned its symposia to a virtual platform.

The most recent symposium titled "Emerging Technologies in the Medical Device Industry" focused on digital intricacies involved in medical product development, artificial intelligence, machine learning, clinical virtual reality, the regulatory framework of the digital world, and cybersecurity. It can be accessed on the SC CTSI digital library here.

To access recordings of past symposia, click here.

Questions about the initiative

Roxy Terteryan
Project Administrator, Regulatory Science Research and Co-Curricular Program

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.